I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD4-positive, alpha-beta T cell | 10 studies | 21% ± 4% | |
| regulatory T cell | 8 studies | 18% ± 2% | |
| mucosal invariant T cell | 7 studies | 20% ± 3% | |
| gamma-delta T cell | 7 studies | 19% ± 6% | |
| CD8-positive, alpha-beta T cell | 6 studies | 23% ± 8% | |
| classical monocyte | 6 studies | 24% ± 8% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 6 studies | 18% ± 3% | |
| T cell | 5 studies | 19% ± 2% | |
| effector memory CD8-positive, alpha-beta T cell | 5 studies | 19% ± 3% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 5 studies | 18% ± 2% | |
| CD8-positive, alpha-beta memory T cell | 4 studies | 20% ± 2% | |
| conventional dendritic cell | 3 studies | 32% ± 11% | |
| non-classical monocyte | 3 studies | 19% ± 1% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 25% ± 7% | |
| ciliated cell | 3 studies | 18% ± 2% | |
| dendritic cell | 3 studies | 26% ± 2% | |
| effector memory CD4-positive, alpha-beta T cell | 3 studies | 21% ± 2% | |
| T follicular helper cell | 3 studies | 18% ± 2% | |
| CD4-positive, alpha-beta memory T cell | 3 studies | 20% ± 6% |
